Literature DB >> 31376394

Amniotic fluid embolism: principles of early clinical management.

Luis D Pacheco1, Steven L Clark2, Miranda Klassen3, Gary D V Hankins4.   

Abstract

Amniotic fluid embolism is an uncommon, but potentially lethal, complication of pregnancy. Because amniotic fluid embolism usually is seen with cardiac arrest, the initial immediate response should be to provide high-quality cardiopulmonary resuscitation. We describe key features of initial treatment of patients with amniotic fluid embolism. Where available, we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle. If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators. Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise. Amniotic fluid embolism-related coagulopathy should be managed with hemostatic resuscitation with the use of a 1:1:1 ratio of packed red cells, fresh frozen plasma, and platelets (with cryoprecipitate as needed to maintain a serum fibrinogen of >150-200 mg/dL). In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood product; cardiac arrest; coagulation; cryoprecipitate; dobutamine; norepinephrine; platelet; right ventricular failure

Year:  2019        PMID: 31376394     DOI: 10.1016/j.ajog.2019.07.036

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Maternal mortality in the United States: research gaps, opportunities, and priorities.

Authors:  Juanita J Chinn; Esther Eisenberg; Shavon Artis Dickerson; Rosalind B King; Nahida Chakhtoura; Issel Anne L Lim; Katherine L Grantz; Charisee Lamar; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2020-07-17       Impact factor: 8.661

2.  Procoagulant Activity in Amniotic Fluid Is Associated with Fetal-Derived Extracellular Vesicles.

Authors:  Kirill R Butov; Natalia A Karetnikova; Dmitry Y Pershin; Dmitry Y Trofimov; Mikhail A Panteleev
Journal:  Curr Issues Mol Biol       Date:  2022-06-13       Impact factor: 2.976

3.  Thrombotic pulmonary embolism of inferior vena cava during caesarean section: A case report and review of the literature.

Authors:  Lan Jiang; Wei-Xiang Liang; Yi Yan; Shou-Ping Wang; Li Dai; Dun-Jin Chen
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

4.  Extracorporeal Membrane Oxygenation for Amniotic Fluid Embolism-Induced Cardiac Arrest in the First Trimester of Pregnancy: A Case Report.

Authors:  Christina Creel-Bulos; Brian Hassani; Michael J Stentz; Gaurav Budhrani; Mani A Daneshmand; Craig S Jabaley; Robert F Groff
Journal:  Crit Care Explor       Date:  2020-07-16

5.  Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.

Authors:  Pedro L Moro; Christine K Olson; Elizabeth Clark; Paige Marquez; Penelope Strid; Sascha Ellington; Bicheng Zhang; Adamma Mba-Jonas; Meghna Alimchandani; Janet Cragan; Cynthia Moore
Journal:  Vaccine       Date:  2022-04-12       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.